To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
2C-B-BZP is 2-bromo-4,5-dimethoxy-benzylpiperazine. It is related to BZP and shares the ring-substitution pattern of the psychedelic phenethylamine 2C-B, although 2C-B-BZP is not a phenethylamine itself.
Reported doses are mainly in the 100-200 mg range.
2C-B-BZP produces stimulant effects that last 3-6 hours, depending on the dose. Despite its structural similarity to 2C-B it does not produce psychedelic effects as the binding groups are in the wrong position to activate the 5HT2A receptor. 2C-B-BZP is also said by several sources to increase the effects of other compounds when combined. Side effects include headaches and nausea, similar to other piperazine derivatives used recreationally.
2C-B-BZP is unscheduled and uncontrolled in the United States, but possession and sales of 2C-B-BZP could possibly be prosecuted under the Federal Analog Act because of its structural similarities to 2C-B or BZP. 2C-B-BZP is said to be illegal to posses, use or sale in Japan where it used to be sold in local smartshops.
The pharmacology of 2C-B-BZP is unknown.
The toxicity of 2C-B-BZP is not known, although Benzylpiperazine (BZP), which is chemically related, has known toxicity.
2C-B-BZP is unknown on the black market, though it is available from research chemical vendors that operate on the internet. It is more common in South Africa than Europe and North America.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "2C-B-BZP". A list of authors is available in Wikipedia.|